Word mark

Trademark: 'PsychiatryLink' 
H. Lundbeck A/S
European Community Trademark, no. 000846881, Word mark


On 10. 6. 1998 the community trademark application no. 000846881 was filed for PsychiatryLink (Word mark) by H. Lundbeck A/S before the OAMI.The goods and services in respect of which registration of the trademark was sought are in classes 41 and 42. The current status of the trademark is application refused.

Status is 'Application refused'
The Community Trade Mark application has been rejected during the registration phase. The refusal may be based on formalities, classification, absolute grounds or relative grounds, i.e. as a result of an opposition.

Applied10. 6. 1998
Nice classes41, 42


You can follow this trademark. You will receive an email, whenever we detect changes of the trademark filing.
This service is for free. You can unsubsribve whenever you want. More information.



H. Lundbeck A/S
Ottiliavej 9
2500 Valby


If you are the trademark owner and the data above are not correct, then please update them soon by clicking on Update address.

If you want to transfer the trademark to another owner, click on Transfer trademark.

You can transfer a trademark partially or completely to another owner. A partial transfer means that you can transfer a trademark in specific classes.

Still questions? Call us : 0049 (0) 89 6666 10 89


No representative yet. Trademark owners outside EU have to appoint a representative. To strenghten a trademark a representative is always recommended.

Appointment of representative


Nice classes

41  Publication of information concerning medicines and diseases.

42  Medical consultancy; providing information concerning medicines and diseases.


Records history

22.1.2017 The current state is Application refused
Current state
22.5.2003 Registered
Proprietor - Change of name and address
15.11.2001 Published
Proprietor - Change of name and address
10.6.1998 Application
Application of the trademark 000846881 PsychiatryLink

Further trademarks of the owner

Cipralex escitalopram Developed to make life easier